Cargando…
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
BACKGROUND: Lack of opportunity for radical surgery and postoperative tumor recurrence are challenges for surgeons and hepatocellular carcinoma (HCC) patients. This study aimed to develop nomograms to predict recurrence risk and recurrence-free survival (RFS) probability after conversion hepatectomy...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492285/ https://www.ncbi.nlm.nih.gov/pubmed/37689775 http://dx.doi.org/10.1186/s40001-023-01310-4 |
_version_ | 1785104219681849344 |
---|---|
author | Deng, Min Zhao, Rongce Guan, Renguo Li, Shaohua Zuo, Zhijun Lin, Wenping Wei, Wei Guo, Rongping |
author_facet | Deng, Min Zhao, Rongce Guan, Renguo Li, Shaohua Zuo, Zhijun Lin, Wenping Wei, Wei Guo, Rongping |
author_sort | Deng, Min |
collection | PubMed |
description | BACKGROUND: Lack of opportunity for radical surgery and postoperative tumor recurrence are challenges for surgeons and hepatocellular carcinoma (HCC) patients. This study aimed to develop nomograms to predict recurrence risk and recurrence-free survival (RFS) probability after conversion hepatectomy for patients previously receiving transarterial interventional therapy. METHODS: In total, 261 HCC patients who underwent conversion liver resection and previously received transarterial interventional therapy were retrospectively enrolled. Nomograms to predict recurrence risk and RFS were developed, with discriminative ability and calibration evaluated by C-statistics, calibration plots, and the Area under the Receiver Operator Characteristic (AUROC) curves. RESULTS: Univariate/multivariable logistic regression and Cox regression analyses were used to identify predictive factors for recurrence risk and RFS, respectively. The following factors were selected as predictive of recurrence: age, tumor number, microvascular invasion (MVI) grade, preoperative alpha‐fetoprotein (AFP), preoperative carbohydrate antigen 19-9 (CA19-9), and Eastern Cooperative Oncology Group performance score (ECOG PS). Similarly, age, tumor number, postoperative AFP, postoperative protein induced by vitamin K absence or antagonist-II (PIVKA-II), and ECOG PS were incorporated for the prediction of RFS. The discriminative ability and calibration of the nomograms revealed good predictive ability. Calibration plots showed good agreement between the nomogram predictions of recurrence and RFS and the actual observations. CONCLUSIONS: A pair of reliable nomograms was developed to predict recurrence and RFS in HCC patients after conversion resection who previously received transarterial interventional therapy. These predictive models can be used as guidance for clinicians to help with treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-023-01310-4. |
format | Online Article Text |
id | pubmed-10492285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104922852023-09-10 Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy Deng, Min Zhao, Rongce Guan, Renguo Li, Shaohua Zuo, Zhijun Lin, Wenping Wei, Wei Guo, Rongping Eur J Med Res Research BACKGROUND: Lack of opportunity for radical surgery and postoperative tumor recurrence are challenges for surgeons and hepatocellular carcinoma (HCC) patients. This study aimed to develop nomograms to predict recurrence risk and recurrence-free survival (RFS) probability after conversion hepatectomy for patients previously receiving transarterial interventional therapy. METHODS: In total, 261 HCC patients who underwent conversion liver resection and previously received transarterial interventional therapy were retrospectively enrolled. Nomograms to predict recurrence risk and RFS were developed, with discriminative ability and calibration evaluated by C-statistics, calibration plots, and the Area under the Receiver Operator Characteristic (AUROC) curves. RESULTS: Univariate/multivariable logistic regression and Cox regression analyses were used to identify predictive factors for recurrence risk and RFS, respectively. The following factors were selected as predictive of recurrence: age, tumor number, microvascular invasion (MVI) grade, preoperative alpha‐fetoprotein (AFP), preoperative carbohydrate antigen 19-9 (CA19-9), and Eastern Cooperative Oncology Group performance score (ECOG PS). Similarly, age, tumor number, postoperative AFP, postoperative protein induced by vitamin K absence or antagonist-II (PIVKA-II), and ECOG PS were incorporated for the prediction of RFS. The discriminative ability and calibration of the nomograms revealed good predictive ability. Calibration plots showed good agreement between the nomogram predictions of recurrence and RFS and the actual observations. CONCLUSIONS: A pair of reliable nomograms was developed to predict recurrence and RFS in HCC patients after conversion resection who previously received transarterial interventional therapy. These predictive models can be used as guidance for clinicians to help with treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-023-01310-4. BioMed Central 2023-09-09 /pmc/articles/PMC10492285/ /pubmed/37689775 http://dx.doi.org/10.1186/s40001-023-01310-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Deng, Min Zhao, Rongce Guan, Renguo Li, Shaohua Zuo, Zhijun Lin, Wenping Wei, Wei Guo, Rongping Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
title | Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
title_full | Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
title_fullStr | Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
title_full_unstemmed | Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
title_short | Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
title_sort | development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492285/ https://www.ncbi.nlm.nih.gov/pubmed/37689775 http://dx.doi.org/10.1186/s40001-023-01310-4 |
work_keys_str_mv | AT dengmin developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT zhaorongce developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT guanrenguo developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT lishaohua developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT zuozhijun developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT linwenping developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT weiwei developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy AT guorongping developmentofnomogramstopredictrecurrenceafterconversionhepatectomyforhepatocellularcarcinomapreviouslytreatedwithtransarterialinterventionaltherapy |